Catalytic specificity of human protein tyrosine kinases revealed by peptide substrate profiling

Current Chemical Genomics

Volumn 5, Issue 1, 2011, Pages 115-121

  Blouin, Julie ^a   Roby, Philippe ^a   Arcand, Mathieu ^a   Beaudet, Lucille ^a   Lipari, Francesco ^a  

^a PerkinElmer Bio discovery   (Canada)

Author keywords

Peptide substrates; Protein tyrosine kinases

Indexed keywords

CYCLIN DEPENDENT KINASE 1; INSULIN RECEPTOR SUBSTRATE 1; JANUS KINASE 1; POLYGLUTAMIC ACID; PROTEIN TYROSINE KINASE;

ARTICLE; CATALYSIS; CONCENTRATION RESPONSE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SPECIFICITY; HUMAN; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; SEQUENCE ANALYSIS; STEREOCHEMISTRY;

EID: 80053491381     PISSN: None     EISSN: 18753973     Source Type: Journal    
DOI: 10.2174/1875397301105010115     Document Type: Article

References (17)

1. Gschwind A, Fischer OM, Ullrich A. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 2004; 4(5): 361-70.
2. Hubbard SR. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 1997; 16(18): 5572-81.
3. Songyang Z, Carraway KL, Eck MJ, et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 1995; 373(6514): 536-9.
4. Zhu H, Klemic JF, Chang S, et al. Analysis of yeast protein kinases using protein chips. Nat Genet 2000; 26(3): 283-9.
5. Cheng HC, Nishio H, Hatase O, Ralph S, Wang JH. A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases. J Biol Chem 1992; 267(13): 9248-56.
6. Shoelson SE, Chatterjee S, Chaudhuri M, White MF. YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proc Natl Acad Sci USA 1992; 89(6): 2027-31.
7. Garcia P, Shoelson SE, George ST, Hinds DA, Goldberg AR, Miller WT. Phosphorylation of synthetic peptides containing Tyr-Met-X-Met motifs by nonreceptor tyrosine kinases in vitro. J Biol Chem 1993; 268(33): 25146-51.
8. Wang R, Griffin PR, Small EC, Thompson JE. Mechanism of Janus kinase 3-catalyzed phosphorylation of a Janus kinase 1 activation loop peptide. Arch Biochem Biophys 2003; 410(1): 7-15.
9. Braun S, Raymond WE, Racker E. Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. J Biol Chem 1984; 259(4): 2051-4.
10. Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene 2000; 19(49): 5548-57.
11. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298(5600): 1912-34.
12. Serfas MS, Tyner AL. Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol Res 2003; 13(6-10): 409-19.
13. Cheng Q, Sasaki Y, Shoji M, et al. Cdk5/p35 and Rho-kinase mediate ephrin-A5-induced signaling in retinal ganglion cells. Mol Cell Neurosci 2003; 24(3): 632-45.
14. Warner N, Wybenga-Groot LE, Pawson T. Analysis of EphA4 receptor tyrosine kinase substrate specificity using peptide-based arrays. FEBS J 2008; 275(10): 2561-73.
15. Davis TL, Walker JR, Allali-Hassani A, Parker SA, Turk BE, Dhe-Paganon S. Structural recognition of an optimized substrate for the ephrin family of receptor tyrosine kinases. FEBS J 2009; 276(16): 4395-404.
16. Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008; 133(1): 38-52.
17. Yin T, Keller SR, Quelle FW, et al. Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases. J Biol Chem 1995; 270(35): 20497-502.